Publish in this journal
Actas Dermo-Sifiliográficas (English Edition)
ISSN: 1578-2190

The Official publication of the Spanish Academy of Dermatology and Venereology (AEDV). Actas Dermo-Sifiliográficas, founded in 1909, is the oldest monthly medical journals published in Spain. In the year 2006 has been indexed in the Medlinedatabase, and has become a vehicle for expressing the most current Spanish medicine and modern. All articles are subjected to a rigorous process of revision in pairs, and careful editing for literary and scientific style. Together with the classic Original and Clinical Case Study sections, we also include Reviews, Case Diagnoses, and Book Reviews. Dermo-Sifiliográficas is an essential publication for anyone who needs to be current on all aspects of Spanish and world dermatology.

See more

Indexed in:

Medline, IME, Embase/Excerpta Medica, Embase, Toxline, Cab Abstracts, Cab Health, Cancerlit NIm, Serline: Biomed, Bibliomed, Pascal, Scopus, IBECS

See more

Follow us:

CiteScore 2018

CiteScore measures average citations received per document published. Read more

CiteScore 2018

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.


SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
Vol. 110. Issue 7.
Pages e17-e18 Pages 517-622 (September 2019)
Sumario en español
Patient-Reported Outcomes in Psoriasis Validated in Spain: PROs and Cons
L. Puig
Actas Dermosifiliogr. 2019;110:518-9
Ixekizumab and Psoriasis in the Real World
I. Belinchón Romero
Actas Dermosifiliogr. 2019;110:520
Evaluation of Sexual Life and Marital Satisfaction in Patients with Anogenital Wart
M. Nahidi, Y. Nahidi, G. Kardan, L. Jarahi, B. Aminzadeh, P. Shojaei, M.R. Fayyazi Bordbar
Actas Dermosifiliogr. 2019;110:521-5
Osler-Weber-Rendu Syndrome in Relation to Dermatology
T.L. Orizaga-y-Quiroga, A. Villarreal-Martínez, G. Jaramillo-Moreno, J. Ocampo-Candiani
Actas Dermosifiliogr. 2019;110:526-32
Consensus document
Spanish Consensus Document on the Treatment Algorithm for Rosacea
M. Salleras, M. Alegre, V. Alonso-Usero, P. Boixeda, J. Domínguez-Silva, J. Fernández-Herrera, X. García-Navarro, N. Jiménez, M. Llamas, C. Nadal, J. del Pozo-Losada, I. Querol, I. Salgüero, M. Schaller, J. Soto de Delás
Actas Dermosifiliogr. 2019;110:533-45
Original articles
A Cost-per-Number Needed to Treat Analysis Assessing the Efficiency of Biologic Drugs in Moderate to Severe Plaque Psoriasis
M. Núñez, T. Huete, P. de la Cueva, J.A. Sacristán, S. Hartz, T. Dilla
Actas Dermosifiliogr. 2019;110:546-53
Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa
S.E. Marrón, M. Gómez-Barrera, L. Tomás-Aragonés, R.M. Díaz Díaz, E. Vilarrasa Rull, M.B. Madrid Álvarez, L. Puig
Actas Dermosifiliogr. 2019;110:554-60
Patient-reported outcomes assessment tools for use in psoriasis in Spain: A systematic review
L. Lizán, C. Gabás-Rivera, I. Belinchón, T. Dilla, T. Huete, S. Díaz
Actas Dermosifiliogr. 2019;110:561-84
Efficacy and Safety of Ixekizumab in a Real-Life Practice: A Retrospective Bicentric Study
J. Magdaleno-Tapial, R. Carmena-Ramón, C. Valenzuela-Oñate, J.M. Ortiz-Salvador, J. Sabater-Abad, P. Hernández-Bel, E. Gimeno-Carpio, J.L. Sánchez-Carazo, A. Pérez-Ferriols
Actas Dermosifiliogr. 2019;110:585-9
Brief comunications
Clinical, Dermoscopic and Histologic Features of Recurrent Cutaneous Eosinophilic Vasculitis Cases
E.G. Quijano-Gomero, M.J.M. Rodríguez-Zúñiga, M.E. Sanz-Montero, D. Durand-Buse
Actas Dermosifiliogr. 2019;110:590-6
Case for diagnosis
Beaded Nodules on the Forearms
I. García Río, S. Heras Gonzalez, M.I. Martínez Gonzalez
Actas Dermosifiliogr. 2019;110:597-8
Indurated Papules on the Face
C. González-Cruz, V. Cabezas, V. García-Patos
Actas Dermosifiliogr. 2019;110:599-600
Resident's forum
FR-Ciclosporin as a First-Line Treatment in Epidermal Necrolysis
D. Morgado-Carrasco, X. Fustà-Novell, P. Iranzo
Actas Dermosifiliogr. 2019;110:601-3
E-images in dermatology
Infarcted Giant Skin Tag
E.C. López-Jiménez, R. Ruiz-Rodríguez, I. Sánchez-Carpintero
Actas Dermosifiliogr. 2019;110:e17
Case and research letters
Dermoscopic Features of Spiradenocylindroma
A. Senarega, L. Flores, A.C. Innocenti, V. Parra
Actas Dermosifiliogr. 2019;110:604-6
Absolute Versus Relative Psoriasis Area and Severity Index in Clinical Practice
E. del Alcázar Viladomiu, N. Lamas Doménech, M. Salleras Redonnet
Actas Dermosifiliogr. 2019;110:606-10
Green, yellow and red hours to go to the beach
O. Correia, A.F. Duarte, A. Picoto
Actas Dermosifiliogr. 2019;110:610-2
Reverse Isotopic Phenomenon in Drug Reaction with Eosinophilia and Systemic Symptoms
M. Adil, Syed Suhail Amin, R. Dinesh Raj, Hera Tabassum
Actas Dermosifiliogr. 2019;110:613-5
Molluscum Contagiosum on the Palms: An Uncommon Location
P. García-Montero, R. Serrano-Pardo, R. Ruiz-Rodríguez, I. Sánchez-Carpintero
Actas Dermosifiliogr. 2019;110:615-7
Morphea «En Coup De Sabre» at the Site of Healed Herpes Zoster Ophthalmicus
T. Arif, M. Adil, S. Suhail Amin, M. Alam
Actas Dermosifiliogr. 2019;110:617-9
Circumscribed Plantar Hypokeratosis
I. Aranguren-López, S. Vildósola-Esturo, I. Arias-Camisón, A. López-Pestaña
Actas Dermosifiliogr. 2019;110:619-21
Actas Dermo-Sifiliográficas (English Edition)

Subscribe to our newsletter

es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.